BioLife Solutions, Inc.

11/05/2025

If you are attending the Informa Connect Life Sciences “Cell & Gene Therapy International Europe 2025” conference in Berlin, Germany on December 1-3, come find us.

Steven Thompson, Andreas Giger and Jordi Marti will be on-site at Stand 7.

This is our first time exhibiting here, so we’re eager to learn what you’re working on. What issues or complexities would you like to improve in your cell and gene therapy R&D or manufacturing workflows? We’re here to discuss, troubleshoot, and find solutions for you. 🧬

If you register by November 7, you will save €200 Euros.
👉 Learn more: https://informaconnect.com/celltherapy/

Bis bald!

11/04/2025

Back in August, we held our first Cell Summit ‘25 meeting for cell and gene therapy development and manufacturing. This event included expert-led discussions and networking in a collaborative format with a focus on CGT solutions, best practices, innovations, and process optimization.

We’ve partnered with Genetic Engineering & Biotechnology News (GEN) to publish a Proceedings eBook of insights from the event. The eBook features contributions from our co-sponsors Azenta Life Sciences, Entegris, and part of our scientific bench - Alireza Abazari, Sean Werner, Jason Acker, and Robert Ben.

How many events provide you with follow-up of actionable insights to make meaningful improvements?

Experience the difference with The Cell Summit. Download the FREE eBook today:
https://promo.genengnews.com/biolife-cell-summit-25-proceedings/

P.S. We can’t wait to share our plans with you for the 2026 event…stay tuned!

10/30/2025

Change is constant. As the cell and gene therapy industry evolves and changes, so have we…

We’re thrilled to announce our NEW website and brand messaging!

We present to you a refreshed visual and verbal identity that is clear, unified, and designed specifically to help you navigate the complexity of cell and gene therapy development and manufacturing.

Our new tagline “Preserving the Promise™” highlights our mission to protect the integrity of cells with our trusted tools, services, and expertise to help you advance science and therapy success.

Check it out: www.biolifesolutions.com

10/28/2025

Biopreservation is central to the success of cell and gene therapy (CGT) manufacturing. Your freezing, storage and thawing processes can directly affect cell viability, downstream workflow success, and therapeutic outcomes.

In our latest blog post, we discuss how partnering with experienced and knowledgeable providers, like BioLife Solutions, can help you protect cell function, optimize processes, and ensure product quality and regulatory compliance.

Highlights:
* The importance of biopreservation
* BioLife Solutions’ scientific leadership and expertise
* Ice crystal growth control and cryoprotectant innovation

Read on: https://go.biolifesolutions.com/l/103972/2025-10-27/5xlg5t

10/23/2025

BioLife Solutions to Report Third Quarter 2025 Financial Results and Business Update on November 6, 2025

Read the press release for webcast and login information.

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's third...

10/23/2025

In four days at the AABB Annual meeting, experts from Pluristyx and BioLife will hold an informal discussion on the possibilities that organoids hold for cell and gene therapy.

Speakers:
Aby J. Mathew, PhD, Executive Vice President & Chief Scientific Officer, BioLife Solutions

Priya Baraniak, Ph.D., VChief Commercial and Development Officer, Pluristyx

Monday, October 27
2:30 – 3:15pm PT
Biotherapies Pavilion (Exhibit Hall F-H)

Please join us for this intriguing discussion!

10/22/2025

Fall conference season is in full swing!

Will we see you at Advanced Therapies USA, November 18-19, in Philadelphia, PA?

Robert Ben of Panthera CryoSolutions (now part of BioLife Solutions) will host a talk called “Controlling ice growth: Mitigating Cryoinjury and Transient Warming Effects to Improve Cellular Therapies”. Check it out on Nov. 18 at 2:15pm in the Innovation Showcase (Track 2, Seminar Theatre).

Add this session to your calendar and make sure to stop by the BioLife booth – 517.

� Review the full agenda: https://www.terrapinn.com/congress/advanced-therapies-usa/agenda.stm

10/21/2025

If you missed our latest webinar on Oct. 9, we have good news for you…it’s available now on-demand on the Cell & Gene Therapy Insights website.

CGT Expert Speakers: Erik Woods (Ossium Health), Jon Pileggi (CTMC), and Sean Werner (BioLife Solutions

Key Takeaways:
* Up to 50% cost reduction by moving from open to closed cell and gene therapy manufacturing

* Lower cleanroom demands and reduced manual handling

* 3x lower fill-finish cost per batch with automated systems

* Modular transition options using the CellSeal® family of storage containers - no full overhaul needed

Watch it here: https://www.insights.bio/cell-and-gene-therapy-insights/webinars/757/closing-the-loop-eliminating-open-handling-risks-in-cgt-manufacturing

10/15/2025

The AABB Annual Meeting in San Diego is 1 ½ weeks away!

Save these must-do activities to your calendar:

* Connect with Andrew Sabatier, Amy Ma, and Joyce Chee at booth 1417.

* Take a lunch break at the Biotherapies Sizzling Topics Luncheon, introduced by *Aby J. Mathew on Sunday, Oct. 26, 11:30am, Room SDCC 28BCDE.

*Attend the Biotherapies Pavilion (Exhibit Hall F-H) discussion with Aby and Pluristyx on Monday, Oct. 27 at 2:30pm. Learn about the potential of patient-derived organoids in precision medicine.

Will we see you there? Learn more: http://www.aabb.org/annual-meeting

10/14/2025

Congratulations to Mary E. Brunkow of Institute for Systems Biology (ISB), Fred Ramsdell of Sonoma Biotherapeutics, and Shimon Sakaguchi of the University of Osaka on receiving the 2025 Noble Prize in Physiology or Medicine.

The laureates discovered the critical role regulatory T cells (Tregs) play in preventing autoimmune diseases. We have a better understanding of how the immune system functions now, which further enables advanced therapy development.

ISB and Sonoma Biotherapeutics are both based in the Seattle area, not far from our HQ in Bothell. What an achievement and milestone for the life sciences industry, patients, and Washington State!

Image Credit: © The Nobel Committee for Physiology or Medicine. Ill. Mattias Karlén

10/09/2025

It’s here, it’s here! Our BioInsights hosted, free webinar goes LIVE in a few hours – 8am PT /11am ET.

Join Erik Woods (Ossium Health), Jon Pileggi (CTMC), and Sean Werner (BioLife Solutions) to hear their discussion on why traditional cryovials and open handling steps introduce risk, complexity, and regulatory burden in cell and gene therapy workflows. �

Register now: https://www.workcast.com/register?cpak=4925825630338704&referrer=BIOLSocial